Some links, and yes, Hexacyclinol…

I’ve been sent a pair of links to pass on to the chemical community:
Director of Teaching and Learning
Department of Chemistry
University of Liverpool
It’s all about using Mathematica’s on-demand information packages to investigate the properties of the 118 elements.http://blog.wolfram.com/2009/02/19/whats-your-favorite-element/I hope you check it out.
We would love to hear your feedback.
Thanks,
Jilyan [Landon]
And now on to Hexacyclinol. Those who pick up my Google Reader feed (on the right, titled ‘What I’m Reading’ will have seen that I noticed the Org. Lett. published by Saielli and Bagno, but I didn’t really feel the need to go over the corpse of this scientific abomination again. Really, let La Clair fade into obscurity. A lot of people, my self included, would like to see some sort of definitive conclusion to this case of synthetic fraud, but it ain’t gonna happen. La Clair isn’t about to announce that he made it all up, so how much more proof can we garner? Without a synthesis of his ‘supposed hexacyclinol’ (I’d rather call it fraudulone, or perhaps fakamycin…), nothing can be proved. Frankly, this would be an enormous waste of money, so lets just let this one go.
I’ve written loads about this in four posts (1, 2 – which contains my opinions, 3, 4), and frankly nothing has changed, other than the fact that some fancy DFT calculations have condemned his proton nmr; Rychnovsky’s carbon prediction was enough for this chemist.
A further note: eagle-eyed readers will have noticed that this blog was up-and-running when the original La Clair bollocks synthesis was published. With such an amazing structure (hmmm…), only one author (*cough, cough*…), and that now worthless Wiley VIP status, you’d think it’d have been a dead cert for me to cover. However, even in my early years I knew the smell of refluxed turd, and decided to stay well clear. If only that prescience extended to knowing which Buchwald Hartwigs will work, and which won’t…












(5 votes, average: 3.80 out of 5)
[...] noticed some buzz in the blogosphere lately (here, here, here, and here) over a recent Org. Lett. paper (DOI: 10.1021/ol900164a) revisiting hexacyclinol—a [...]
Hmm. As you can see above, the ACS has waded into the hexacyclinol debate with a scathing indictment of the Angewandte
lack ofpeer review. However, to me this smacks of more than a little ‘pot calling the kettle black’. Sure, hexacyclinol was a bad ‘un though…[...] 3. I'm not going to exhaustively re-cover the hexacyclinol debacle here. A good summary was written by Derek over at In The Pipeline back when a relevant paper last came out, in 2009. The route itself, for those without literature access, can be enjoyed in this Wipf group meeting presentation and the relevent Tot. Syn. posts. [...]